Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
β-blocker dosage and outcomes after acute coronary syndrome
Jason E. Allen
, Stacey Knight
, Raymond O. McCubrey
, Tami Bair
, Joseph Brent Muhlestein
, Jeffrey J. Goldberger
, Jeffrey L. Anderson
Medicine - Cardiology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
22
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'β-blocker dosage and outcomes after acute coronary syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Beta-blockers
100%
Acute Coronary Syndrome
100%
High Dose
77%
Adverse Cardiac Events
55%
Hazard Ratio
33%
Myocardial Infarction
22%
Healthcare
11%
All-cause Mortality
11%
2-dose
11%
Multivariate Analysis
11%
Metoprolol
11%
Daily Dose
11%
Coronary Stenosis
11%
Decreased Risk
11%
Intermediate Dose
11%
Event Outcomes
11%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
100%
Major Adverse Cardiac Event
71%
Heart Infarction
28%
Cerebrovascular Accident
14%
Coronary Artery Obstruction
14%
Metoprolol
14%